# A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

> **NCT02897219** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 175 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** ipragliflozin
- **DRUG:** Placebo
- **OTHER:** Insulin Therapy

## Key facts

- **NCT ID:** NCT02897219
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-29
- **Primary completion:** 2017-07-22
- **Final completion:** 2018-03-15
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02897219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02897219, "A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02897219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*